Skip to content
Clinical Trials – home

H2-Receptor Antagonists: A Comprehensive Guide for Patients

6 / 10
trials open to patients / all trials
19+
Countries

In short

This article examines several clinical trials investigating the use of H2-Receptor Antagonists in various cancer treatments. These trials aim to evaluate the safety and efficacy of H2-Receptor Antagonists, either alone or in combination with other drugs, for different types of cancer including breast cancer, lung cancer, cervical cancer, and gastrointestinal cancers. The studies focus on patients with advanced or metastatic stages of these cancers, exploring potential new treatment options.

What are H2-Receptor Antagonists?

H2-receptor antagonists, also known as H2 blockers, are a class of medications used primarily to treat conditions related to excess stomach acid. These drugs work by blocking histamine receptors in the stomach, which helps reduce the production of stomach acid.

How do H2-Receptor Antagonists Work?

To understand how H2-receptor antagonists work, it's important to know about histamine and its role in the body. Histamine is a chemical that triggers the release of stomach acid. H2-receptor antagonists block the histamine receptors on the cells in the stomach that produce acid. By doing this, they reduce the amount of acid produced, which can help alleviate symptoms associated with excess stomach acid.

Medical Uses of H2-Receptor Antagonists

H2-receptor antagonists are commonly used to treat several conditions related to excess stomach acid, including:

  • Gastroesophageal reflux disease (GERD): A condition where stomach acid frequently flows back into the esophagus
  • Peptic ulcers: Sores that develop on the lining of the stomach or small intestine
  • Dyspepsia: A term for stomach discomfort, which can include symptoms like nausea, bloating, and burping
  • Zollinger-Ellison syndrome: A rare condition that causes tumors in the pancreas and duodenum, leading to increased stomach acid production

These medications can provide relief from symptoms such as heartburn, acid indigestion, and stomach pain.

Administration and Dosage

H2-receptor antagonists are available in various forms, including tablets, liquids, and injections. The most common route of administration is oral, but in some cases, they may be given intravenously in a hospital setting. The dosage and frequency of administration depend on the specific condition being treated and the individual patient's needs. It's crucial to follow your doctor's instructions or the guidance provided on the medication label.

Potential Side Effects

While H2-receptor antagonists are generally well-tolerated, like all medications, they can cause side effects in some people. Common side effects may include:

  • Headache
  • Dizziness
  • Diarrhea or constipation
  • Nausea or vomiting
  • Fatigue

More serious side effects are rare but can include changes in heart rhythm, confusion (especially in older adults), and liver problems. If you experience any unusual or severe side effects, it's important to contact your healthcare provider immediately.

Ongoing Research and Clinical Trials

While H2-receptor antagonists have been used for decades to treat acid-related conditions, ongoing research is exploring their potential in other areas of medicine. Several clinical trials are currently investigating the use of H2-receptor antagonists in combination with other drugs for various types of cancer.

For example, studies are looking at the combination of H2-receptor antagonists with immunotherapy drugs like pembrolizumab in treating cancers such as:

  • Breast cancer
  • Non-small cell lung cancer (NSCLC)
  • Gastric and gastroesophageal cancers
  • Cervical cancer
  • Colorectal cancer
  • Pancreatic cancer
  • Biliary tract cancer

These studies aim to evaluate the safety and efficacy of these combination therapies in improving outcomes for cancer patients. However, it's important to note that these are still in the research phase, and more evidence is needed before any conclusions can be drawn about their effectiveness in cancer treatment.

Conclusion

H2-receptor antagonists play a crucial role in managing conditions related to excess stomach acid. They offer relief for millions of people suffering from GERD, ulcers, and other gastrointestinal issues. While they are primarily used for acid-related conditions, ongoing research is exploring their potential in other areas of medicine, including cancer treatment. As with any medication, it's important to use H2-receptor antagonists under the guidance of a healthcare professional and to be aware of potential side effects. If you have any concerns or questions about H2-receptor antagonists, don't hesitate to discuss them with your doctor.

Questions people often ask

Conditions where H2-Receptor Antagonists is being studied

Each condition opens its own overview and trial list

Trials with H2-Receptor Antagonists

Recruiting trials first

See all 10 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).